Home › Trial NCT01560663
Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer
- Trial IDNCT01560663
- StatusUnknown
- PhaseN/A
- Study typeObservational
- SponsorMiguel Martín Jiménez
- Enrollment415
- Start date2012-01
- ConditionsBreast Cancer · Breast Cancer Stage II-III
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.